open access

Vol 76, No 7 (2018)
Short communications
Published online: 2018-07-06
Submitted: 2018-05-03
Accepted: 2018-05-23
Get Citation

Association of cardiac troponin I with prothrombotic alterations in atrial fibrillation

Paweł T. Matusik, Shannon M. Prior, Saulius Butenas, Barbara Małecka, Jacek Lelakowski, Anetta Undas
DOI: 10.5603/KP.2018.0134
·
Kardiol Pol 2018;76(7):1106-1109.

open access

Vol 76, No 7 (2018)
Short communications
Published online: 2018-07-06
Submitted: 2018-05-03
Accepted: 2018-05-23

Abstract

Not available

Abstract

Not available
Get Citation
Supplementary Files (1)
Supplementary Tables
Download
36KB
About this article
Title

Association of cardiac troponin I with prothrombotic alterations in atrial fibrillation

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 7 (2018)

Pages

1106-1109

Published online

2018-07-06

DOI

10.5603/KP.2018.0134

Bibliographic record

Kardiol Pol 2018;76(7):1106-1109.

Authors

Paweł T. Matusik
Shannon M. Prior
Saulius Butenas
Barbara Małecka
Jacek Lelakowski
Anetta Undas

References (13)
  1. Drabik L, Wołkow P, Undas A. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation. Thromb Res. 2015; 136(2): 408–414.
  2. Hijazi Z, Lindbäck J, Alexander JH, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016; 37(20): 1582–1590.
  3. Matusik PT, Matusik PS, Kornacewicz-Jach Z, et al. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation. Int J Cardiol. 2017; 243: 244–250.
  4. Goldman S, Prior SM, Bembenek JP, et al. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA. J Thromb Thrombolysis. 2017; 44(3): 362–370.
  5. Skeppholm M, Kallner A, Malmqvist K, et al. Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome? Thromb Res. 2011; 128(5): 483–489.
  6. Hemker HC, Al Dieri R, De Smedt E, et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost. 2006; 96(5): 553–561.
  7. Hijazi Z, Siegbahn A, Andersson U, et al. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2015; 61(2): 368–378.
  8. Osmancik P, Louckova A. Biomarkers of apoptosis, inflammation, and cardiac extracellular matrix remodelling in the prognosis of heart failure. Kardiol Pol. 2017; 75(4): 295–305.
  9. Matusik PT, Tomala I, Piekarz I, et al. Thyroid goiter: implications for implantation of cardiovascular implantable electronic devices and cannulation of the superior vena cava confluence. Pol Arch Med Wewn. 2016; 126(6): 432–434.
  10. Hijazi Z, Siegbahn A, Andersson U, et al. High-Sensitivity troponin i for risk assessment in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation. 2013; 129(6): 625–634.
  11. Hohnloser SH, Hijazi Z, Thomas L, et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012; 33(22): 2821–2830.
  12. Kızılırmak F, Gokdeniz T, Gunes HM, et al. Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence. Kardiol Pol. 2017; 75(2): 126–134.
  13. Etgen T, Baum H, Sander K, et al. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke. 2005; 36(2): 270–275.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl